Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Zero based budgeting assigns every dollar a purpose, improving allocation and reducing waste. Implement these techniques to strengthen financial management today.
25,432 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
XRP trades near the $0.72 mark in early July 2026 as AI-driven forecasts weigh regulatory and macro factors. The pric...
Public hearings and local politics are slowing housing supply, hitting renters and buyers with higher costs. This rep...
Markets rally as AI progress accelerates, steering investment toward compute, energy, and robotics. Analysts warn the...
JPMorgan Chase delivered a record quarterly performance, yet Jamie Dimon cautioned that the current market sprint cou...
Bitcoin briefly rose above $65k but failed to hold, with on-chain data showing selling pressure from both new buyers ...
A fresh group of stocks tied to memory chips is redefining global markets as AI data centers push demand higher. The ...
CrowdStrike has pulled back from recent highs. Before March 3 earnings, investors wonder if a dip offers a real buyin...
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
As markets wobble, retirees quickly moving into dividend ETFs are turning to steady income. This piece analyzes three...
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
Oil approaching $100 per barrel could upend retail economics. Walmart appears best positioned to weather an energy-dr...